Acurox NDA: FDA schedules Advisory Committee meeting Acura Pharmaceuticals, Inc. , Inc. today announced that the U.S. The scheduled interacting with will be a joint interacting with of the Anesthetic and Existence Support Medicines and the Drug Security and Risk Management Advisory Committees.And longer-term work is required to see whether the decreased grid cell function actually predicts Alzheimer’s. ‘Right now, we’ve zero therapies that prevent Alzheimer’s,’ Gilberto said. But if so when such treatments become available, doctors shall need reliable methods to pinpoint high-risk individuals who could benefit. Biological markers are also needed to find a very good candidates for clinical trials testing experimental therapies, Gilberto said. Dean Hartley, director of science initiatives for the Alzheimer’s Association, agreed that the analysis outcomes hint at a possible new biological marker.